Severe nonanaphylactic allergic reaction to the Pfizer-BioNTech COVID-19 vaccine
Sign Up to like & getrecommendations! Published in 2021 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2021.11.015
Abstract: INTRODUCTION The Pfizer-BioNTech COVID-19 vaccine was first approved for use in December 2020. Studies have shown the vaccine to be highly effective at preventing transmission of SARS-CoV-2 and reducing the severity of COVID-19. Reported side… read more here.
Keywords: covid vaccine; pfizer biontech; biontech covid; nonanaphylactic allergic ... See more keywords